 | |
| Legal status | |
|---|---|
| Legal status | |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C16H26N2O2S |
| Molar mass | 310.46 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
 N Y (what is this?) (verify) | |
A-836,339 is a drug developed byAbbott Laboratories that acts as a potentcannabinoidreceptorfull agonist. It is selective forCB2, withKi values of 0.64 nM at CB2 vs 270 nM at the psychoactiveCB1 receptor, but while it exhibits selectiveanalgesic,anti-inflammatory andanti-hyperalgesic effects at low doses,[1] its highefficacy at both targets results in typical cannabis-like effects appearing at higher doses, despite its low binding affinity for CB1.[2] In 2012 A-836,339 was detected viaX-ray crystallography in a "dubious product" sold in Japan, though the product was described as a white powder, notherbal incense, it was suggested to be for human consumption.[3]
 | Thiscannabinoid related article is astub. You can help Wikipedia byexpanding it. |
